Detalhe da pesquisa
1.
Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant.
Eur J Clin Pharmacol
; 78(4): 613-621, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35039908
2.
Exacerbation of atrioventricular block associated with concomitant use of amlodipine and aprepitant in a lung cancer patient: A case report.
Int J Clin Pharmacol Ther
; 59(4): 328-332, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33355084
3.
Profile of the inhibitory effects of gefitinib on CYP2D6 variants in vitro.
Int J Clin Pharmacol Ther
; 58(10): 539-542, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32691726